This article is more than 5 years old. Information may no longer be current.

VIDEO: Allergan seeks to expand footprint with retinal therapy pipeline

ByJag Dosanjh

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

CHICAGO — At the Ophthalmology Innovation Summit at AAO, Jag Dosanjh, senior vice president of eye care for Allergan, discusses two new potential treatments for wet age-related macular degeneration and geographic atrophy progressing through clinical trials. Dosanjh also discusses progress in glaucoma and pharmaceutical presbyopia-correcting technology.